Jessica Hagen

MAI-DxO AI reportedly diagnosed complex medical cases with over four times higher accuracy than generalist physicians and saved costs.

The acquisition, part of a strategic partnership to accelerate Arcadia's growth and innovation, marks an exit for former investor Peloton Equity.

The sale drew mixed reactions, with some U.S. states supporting it as a privacy measure and others objecting over legal and data concerns.

The company offers mental healthcare for children and their families and will use the funds to expand its reach.

The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging the company engages in deceptive marketing and illegally sells copycat drugs.

The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications. 

Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle-machine interface that allows individuals with limb loss to control robotic limbs and systems using electrical activity from their own muscles.

The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.

The Series E funding comes four months after the company secured $250 million in a Series D round.

Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.